These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34891704)

  • 21. Telltale silence: temporal speech parameters discriminate between prodromal dementia and mild Alzheimer's disease.
    Vincze V; Szatlóczki G; Tóth L; Gosztolya G; Pákáski M; Hoffmann I; Kálmán J
    Clin Linguist Phon; 2021 Aug; 35(8):727-742. PubMed ID: 32993390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Machine Learning Analysis of Digital Clock Drawing Test Performance for Differential Classification of Mild Cognitive Impairment Subtypes Versus Alzheimer's Disease.
    Binaco R; Calzaretto N; Epifano J; McGuire S; Umer M; Emrani S; Wasserman V; Libon DJ; Polikar R
    J Int Neuropsychol Soc; 2020 Aug; 26(7):690-700. PubMed ID: 32200771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Easy Screening for Mild Alzheimer's Disease and Mild Cognitive Impairment from Elderly Speech.
    Kato S; Homma A; Sakuma T
    Curr Alzheimer Res; 2018; 15(2):104-110. PubMed ID: 29165082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in Speech Chunking in Reading Aloud is a Marker of Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease.
    De Looze C; Kelly F; Crosby L; Vourdanou A; Coen RF; Walsh C; Lawlor BA; Reilly RB
    Curr Alzheimer Res; 2018; 15(9):828-847. PubMed ID: 29623841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linguistic Features Identify Alzheimer's Disease in Narrative Speech.
    Fraser KC; Meltzer JA; Rudzicz F
    J Alzheimers Dis; 2016; 49(2):407-22. PubMed ID: 26484921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Language Impairment in Alzheimer's Disease-Robust and Explainable Evidence for AD-Related Deterioration of Spontaneous Speech Through Multilingual Machine Learning.
    Lindsay H; Tröger J; König A
    Front Aging Neurosci; 2021; 13():642033. PubMed ID: 34093165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lexical factors and cerebral regions influencing verbal fluency performance in MCI.
    Clark DG; Wadley VG; Kapur P; DeRamus TP; Singletary B; Nicholas AP; Blanton PD; Lokken K; Deshpande H; Marson D; Deutsch G
    Neuropsychologia; 2014 Feb; 54():98-111. PubMed ID: 24384308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances on Automatic Speech Analysis for Early Detection of Alzheimer Disease: A Non-linear Multi-task Approach.
    Lopez-de-Ipina K; Martinez-de-Lizarduy U; Calvo PM; Mekyska J; Beitia B; Barroso N; Estanga A; Tainta M; Ecay-Torres M
    Curr Alzheimer Res; 2018; 15(2):139-148. PubMed ID: 29165084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing Pre-trained and Feature-Based Models for Prediction of Alzheimer's Disease Based on Speech.
    Balagopalan A; Eyre B; Robin J; Rudzicz F; Novikova J
    Front Aging Neurosci; 2021; 13():635945. PubMed ID: 33986655
    [No Abstract]   [Full Text] [Related]  

  • 33. Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment.
    Xu L; Wu X; Chen K; Yao L
    Comput Methods Programs Biomed; 2015 Nov; 122(2):182-90. PubMed ID: 26298855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breaking the flow of thought: Increase of empty pauses in the connected speech of people with mild and moderate Alzheimer's disease.
    Lofgren M; Hinzen W
    J Commun Disord; 2022; 97():106214. PubMed ID: 35397387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connected Speech Deficit as an Early Hallmark of CSF-defined Alzheimer's Disease and Correlation with Cerebral Hypoperfusion Pattern.
    Mazzon G; Ajčević M; Cattaruzza T; Menichelli A; Guerriero M; Capitanio S; Pesavento V; Dore F; Sorbi S; Manganotti P; Marini A
    Curr Alzheimer Res; 2019; 16(6):483-494. PubMed ID: 31057108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
    Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
    Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
    Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
    Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Time-sparing screening method for mild cognitive impairment and early Alzheimer's disease: Self- and family reports using the TMIG index of competence].
    Akasaka H; Yonezawa H; Takahashi J; Obara S; Shibata T; Suzuki M; Ishizuka N; Sato M; Kudo M; Terayama Y; Maeda T
    Nihon Ronen Igakkai Zasshi; 2020; 57(2):182-194. PubMed ID: 32475946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.